Is the mean blood leukocyte telomere length a predictor for sporadic thoracic aortic aneurysm? Data from a preliminary study.

Telomeres have been postulated as a universal clock that shortens in parallel with cellular aging. They are specialized DNA-protein structures at the ends of chromosome with remarkable functions--preventing their recognition as double-stranded DNA breaks, protecting their recombination and degradation, and avoiding a DNA damage cellular response. Telomere shortening is currently considered the best aging marker, but is also a predictor for age-related diseases, including cardiovascular diseases. Biological age clearly seems to be a better predictor of vascular risk rather than chronological age. This concept is supported by key assumptions that peripheral blood leukocyte telomere content accurately reflects that of the vascular wall and its decrease is associated with premature vascular disease. Thus, we are analyzing whether the mean of blood leukocyte telomere length might also be a predictor for sporadic thoracic aortic aneurysm (S-TAA). The preliminary results seem to be promising. Shorter telomeres were detected in patients than in controls. Thus, mean of blood leukocyte telomere length could contribute to identify individuals at S-TAA risk.

[1]  E. Rietzschel,et al.  Telomere length and cardiovascular aging: The means to the ends? , 2011, Ageing Research Reviews.

[2]  R. Kronmal,et al.  Leukocyte telomere length and mortality in the Cardiovascular Health Study. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  P. van der Harst,et al.  Healthy aging and disease: role for telomere biology? , 2011, Clinical science.

[4]  A. Mainous,et al.  Telomere length as a risk marker for cardiovascular disease: the next big thing? , 2010, Expert review of molecular diagnostics.

[5]  L. Rochette,et al.  Telomere length and cardiovascular disease. , 2010, Archives of cardiovascular diseases.

[6]  N. Samani,et al.  Leukocyte Telomere Length is Associated with Abdominal Aortic Aneurysm ( AAA ) , 2010 .

[7]  David M. Williams,et al.  2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame , 2010, Journal of the American College of Cardiology.

[8]  J. Elefteriades,et al.  Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. , 2010, Journal of the American College of Cardiology.

[9]  R. D. de Boer,et al.  The emerging role of telomere biology in cardiovascular disease. , 2010, Frontiers in bioscience.

[10]  Souvik Sen,et al.  2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame , 2010, Circulation.

[11]  Magdi H. Yacoub,et al.  Cellular and molecular mechanisms of thoracic aortic aneurysms , 2009, Nature Reviews Cardiology.

[12]  Nancy E. Adler,et al.  The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men , 2008, Aging.

[13]  S. Stevens,et al.  Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. , 2008, European heart journal.

[14]  Marco Caruso,et al.  Pharmacogenomics: a tool to prevent and cure coronary heart disease. , 2007, Current pharmaceutical design.

[15]  Guohua Li,et al.  Injury prevention and control. , 2007, Emergency medicine clinics of North America.

[16]  C. Nienaber,et al.  Etiology, pathogenesis and management of thoracic aortic aneurysm , 2007, Nature Clinical Practice Cardiovascular Medicine.

[17]  Claudio Franceschi,et al.  Innate immunity and inflammation in ageing: a key for understanding age-related diseases , 2005, Immunity & Ageing.